Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats

Cancer Immunology, Immunotherapy

Volumn 56, Issue 8, 2007, Pages 1207-1214

  Djalilian, Hamid R ^a   Caicedo, Emiro ^a   Lessan, Khashayar ^a   Grami, Vahid ^a   Le, Chap T ^a   Spellman, Stephen R ^a   Pambuccian, Stephan ^a   Hall, Walter A ^a   Low, Walter C ^a   Ondrey, Frank G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Head and neck cancer; Immunotherapy; Interleukin 12; Rat model

Indexed keywords

CANCER VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER IMMUNIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; EXPERIMENTAL RAT; GASTROINTESTINAL CARCINOMA; GROWTH RATE; INOCULATION; IRRADIATION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR IMMUNITY; UPPER GASTROINTESTINAL TRACT;

ANIMALS; CANCER VACCINES; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FEASIBILITY STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY, ACTIVE; INDOMETHACIN; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-12; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MICE; NEOPLASM TRANSPLANTATION; OSMOSIS; PHARYNGEAL NEOPLASMS; RATS; RATS, INBRED F344; SINGLE-BLIND METHOD; TUMOR BURDEN;

EID: 34248586072     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-006-0271-2     Document Type: Article

References (33)

1. Cohen E, Lingen M, Vokes E (2004) The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22(9):1743-1752
2. Berlinger N (1984) Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins. Laryngoscope 94:107-112
3. Pardoll DM (1995) Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 13:399-415
4. Dranoff G, Jaffee E, Lazenby A, et al (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte/macrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543
5. Levitsky HI, Montgomery J, Ahmadzadeh M, et al (1996) Immunization with granulocyte/macrophage colony-stimulating factor, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generate potent systemic antitumor immunity. J Immunol 156:3858-3865
6. Sanda MG, Ayyagar SR, Jaffee EM, et al (1994) Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151:622-628
7. Simons JW, Jafee EM, Weber CE, et al (1997) Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-monocyte colony stimulating factor gene transfer. Cancer Res 57:1537-1546
8. Hadden J, Verastegui E, Barrera J, Kurman M, Meneses A, Zinser J, de la Garza J, Hadden E (2003) A trial of IRX-2 in patients with squamous cell carcinoma of the head and neck. Int Immunopharmacol 3(8):1073-1082
9. Wallenfriedman MA, Conrad JA, DelaBarre L, et al (1999) Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression. J Neurosurg 90(6):1064-1071
10. Jean WC, Spellman SR, Wallenfriedman MA, et al (1998) Interleukin-12-based immunotherapy against rat 9L glioma. Neurosurgery 42(4):850-856
11. Jean WC, Spellman SR, Wallenfriedman MA, Flores CT, Kurtz BP, Hall WA, Low WC (2004) Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat. J Neurooncol 66(1-2):39-49
12. Djalilian HR, Lessan K, Spellman S, Pambuccian S, Low WC, Hall WA, Ondrey FG (2004) A new immune-competent animal model of mucosally derived squamous cell carcinoma. Otolaryngol Head Neck Surg 131(5):781-783
13. Bermudez E, Chen Z, Gross EA, Walker CL, Recio L, Pluta L, Morgan KT (1994) Characterization of cell lines derived from formaldehyde-induced nasal tumors in rats. Mol Carcinog 9(4):193-199
14. Smith CJ, Perfetti TA, Rumple MA, Rodgman A, Doolittle DJ (2000) "IARC group 2A carcinogens" reported in cigarette mainstream smoke. Food Chem Toxicol 38(4):371-383
15. Potter M, Wax JS, Anderson AO, Nordan RP (1985) Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J Exp Med 161(5):996-1012
16. Martinet O, Ermekova V, Qiao JQ, Sauter B, Mandeli J, Chen L, Chen SH (2000) Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long-term remission of liver metastases in a mouse model. J Natl Cancer Inst 92(11):931-936
17. Sklarin NT, Chahinian AP, Feuer EJ, Lahman LA, Szrajer L, Holland JF (1988) Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice. Cancer Res 48(1):64-67
18. Panje WR (1981) Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol Head Neck Surg 107:658-660
19. Cross D, Platt J, Juhn S, Bach F, Adams G (1992) Administration of a prostaglandin synthesase inhibitor associated with an increased immune cell inWltrate in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 118(5):526-528
20. Wanebo HJ, Jun MY, Strong EW, Oettgen H (1975) T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 130(4):445-451
21. Jean WC, Spellman SR, Wallenfriedman MA, Flores CT, Kurtz BP, Hall WA, Low WC (2004) Effects of combined granulocyte-macrophage colony-stimulating factor (GMCSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat. J Neurooncol 66(1-2):39-49
22. Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H, et al (2004) Correlation of histological localization of tumor associated macrophages with clinicopathological features in endometrial cancers. Anticancer Res 24(5c):3335-3342
23. Ohno S, Inagawa H, Dhar D, Ueda S, Tachibana M, et al (2003) The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23(6d):5015-5022
24. Cross DS, Ondrey FG, Juhn SK, et al (1994) Prostaglandins and host immune response in squamous cell carcinoma of the head and neck. In: Harris JE, Braun DP, Anderson KM (eds) Prostaglandin inhibitors in tumor immunology and immunotherapy. CRC, Cleveland, pp 129-169
25. Kerrebijn JD, Simons PJ, Balm AJM, et al (1996) Thymo-stimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma. Head Neck 18:335-342
26. Pardoll DM (1998) Cancer vaccines. Nat Med 4(5):525-531
27. Maisel RH, Ogura JH (1976) Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer. Ann Otolaryngol 85:517-522
28. Ferris R (2004) Progress in head and neck cancer immunotherapy: can tolerance ad immune suppression be reversed? ORL 66:332-340
29. Reichert TE, Rabinowich H, Johnson J, Whiteside TL (1998) Immune cells in the tumor microenvironment. Mechanisms responsible for functional defects. J Immunother 21:295
30. Whiteside T (2002) Tumor-induced death of immune cells: its mechanism and consequences. Semin Cancer Biol 12:43
31. Ondrey FG, Dong G, Sunwoo J, Chen Z, Wolf JS, Crowl-Bancroft CV, Mukaida N, Van Waes C (1999) Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 26(2):119-129
32. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5(6):1369-1379
33. Smith CW, Chen Z, Dong G, Loukinova E, Pegram MY, Nicholas-Figueroa L, Van Waes C (1998) The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC. Clin Exp Metastasis 16(7):655-664